October 28 – 29, 2019
Healthcare Gets Personal
This year at MTIF is shaping up to be one of our most impactful yet! With top tier presenting companies, representatives from over 300 leading companies and exhibits and panels from around the world, this MTIF highlights the future of personalized healthcare in Medical Technology. This year, we’re introducing a new limited session that will allow attendees to directly with industry experts. You can learn more here.
The Future of Medicine is Here
This year at MTIF is shaping up to be one of our most impactful yet! With top tier presenting companies, representatives from over 300 leading companies and exhibits and panels from around the world, this MTIF highlights the future of MedTech in Southern California.
MTIF 2019 Agenda
- Oct. 28
- Oct. 29
Registration, Networking & Exhibits
Welcome Address: Accelerating Success
OCTANe CEO Bill Carpou opens up the 2019 Medical Technology Innovation Forum with a focus on the current MedTech ecosystem in Southern California and what the future holds for growth in Orange County
Keynote: AI Med- Artificial Intelligence in Medicine
Dr. Chang’s keynote will highlight common misconceptions about AI in medicine. Additionally, he will discuss the future of AI and the role it will play in the practice of medicine.
Dr. Anthony C. Chang, MBA, MPH, MS, Pediatric Cardiology, Chief Intelligence & Innovation Officer, Sharon Disney Lund Medical Intelligence and Innovation Institute (MI3), CHOC Children’s
Future of Healthcare- The Role of Personalized Medicine
Better diagnoses, earlier interventions, more-efficient drug therapies, customized treatment plans. These are the promises of personalized medicine. Individualized, precision or personalized medicine provides a genomic blueprint to determine each person’s unique disease susceptibility, define preventive measures and enable targeted therapies to promote wellness. Our panelists will provide their unique perspectives on what the future holds for personalized medicine.
Clay Wilemon, Chief Strategy Officer & President – Brand Activation, BRADO (Moderator)
Steve Keiles, Senior Director, Genomic Services, Advanced Diagnostics, Quest Diagnostics
Patrick Lilley, Founder & CEO, Liquid Biosciences
Shaista Malik, MD, PhD, MPH, Associate Vice Chancellor, Integrative Health & Executive Director, Susan Samueli Integrative Health Institute
Annette Walker, President, City of Hope Orange County
Break & 1:1 Meetings
Industry Track: What’s New in Clinical Trials
This panel will discuss requirement of Clinical Trails, educate attendees on domestic vs international options for clinical trails and why trials matter for clearance, CMS and marketing.
Bruce Feuchter, Shareholder, Stradling (Moderator)
Bobak Azamian, MD, PhD, CEO, Tarsus Pharmaceuticals
Marina Bejanian, PhD, Executive Director, Clinical Development, Allergan
Janice Sidorick, CEO, Janix (CRO)
International Track: EU Regulatory Update: MDR/IVDR/ Brexit
An update on current status of BREXIT. What does BREXIT mean for companies in the US and Britain? What are the tax and legal implications? What are the implications for doing business in the rest of Europe?
Kevin Depew, Deputy Chief Economist, RSM (Moderator)
Alison Dennis, Partner, Field Fisher
Mike Howells, Consul General, British Consulate
Patrick Johnson, President & CEO, Celluma
Break & 1x1 Meetings
Lunch: Keynote Speaker- Jim Fallon, Professor, UCI, Neuroscientist, Best Selling Author
Through research he explores the way genetic and perinatal environmental factors affect the way the brain gets built — and then how an individual’s experience further shapes his or her development. But Fallon’s research on psychopaths and murderers made a strange and personal turn. With PET scans and genetics , he uncovered the deep, underlying traits that make people violent and murderous.
Introduction & Q&A: Linda DiMario, Executive Vice President, Greater Irvine Chamber of Commerce
Jim Fallon, Professor, UCI, Neuroscientist
Break & 1x1 Meetings
Industry Track: Heathcare-On-The-Go
Panel participants will focus on the future of care, the changing medical landscape, and whether telemedicine makes healthcare more affordable.
Jessica Achtsam, Partner, Knobbe Martens (Moderator)
Robert Allison, Principal & Managing Director, Innovate Partners
Justin Zaghi, MD, Medical Director, Heal.com
Jenna Mons, CEO CONCIERGE KEY Health, Inc.
International Track: Reality Check-Doing Business in China
This session will focus on the the challenges of doing business in China: avoiding the pitfalls and how to find trusted partners while doing business in the country.
John Cox, President & CEO, FRESCA Medical (Moderator)
Chris Lo, Director, Hong Kong Trade Development Council
Paul DeRidder, MD, MBA, President, BioValleyCHINA
Grace Fu Palma, President and CEO of ChinaMed Device LLC
Andrew Pan, Senior Vice President, Head of China Business & Strategy, East West Bank’s
The Innovation Agenda – Getting Life Saving Products to Market
Overall – Despite the pressure to improve efficiency and reduce costs, medtech companies are still looking to innovate. Companies are looking to non-traditional partners to help drive innovation agenda and collaborate with outside organizations. How is the financial pressure from health care reform, the transition to value-based health care, tougher insurance coverage and increased regulatory requirements affecting innovation? The panelists discuss innovation and what they see in the future of innovation in medtech.
Len Brandt, General Partner, Norwest Ventures (Moderator)
Irina Kulinets, PhD, RAC, CQE, Sr. Vice President of Regulatory
Affairs, Clinical Research & Quality, MicroVention, Inc., A TERUMO Group Company (Moderator)
Daniela A. Bota, MD, PhD, Neuro-Oncology, UC Irvine
Jonathon Lobbins, Vice President, Advanced Therapies, Siemens Healthineers
Industry Track: Future of Mental Health
Hear from leaders of Be Well OC- a transformative first of its kind-initiative bringing together public, private, academic and faith based organizations to coordinate a coordinated system of mental health and support. What is the latest innovation in mental health treatment? How do you personalize treatment?
Richard Afable, MD, MPH, President & Board Member, MindOC (Moderator)
Clayton Chau, MD, PhD, Chief Clinical Officer, MindOC
Marshall Monchief, CEO, MindOC
Break & 1x1 Meetings
Panel Discussion: Medical Innovation in Aesthetics
Panelists in this session will facilitate the exchange of insights on emerging trends and innovation in medical aesthetics.
Scott Whitcup, MD, Founder and CEO, Akrivista and Whitecap Biosciences (Moderator)
Natasha Mesinkovska, MD, Dermatology Specialist, UC Irvine Medical Center
Darin Messina, PhD, Vice President of Device Biology R&D, Allergan
Edward Ross, MD, Dermatologist, Scripps
Steve Yoelin, MD, Cosmetic Surgeon
Chris Zachary, MD, Chair & Professor – Dermatology, UC Irvine School of Medicine
Panel Discussion: The State of Affairs for Medical Cannabis
Despite its controversial nature, medical marijuana use and legal adoption continues to expand nationwide.
Kim Kovacs, Managing Director of Arroyo Ventures, President, Los Angeles Venture Association (LAVA), & Founderr, MyJane (Moderator)
Ashley Chiu, Cannabis Strategy and Risk Advisor, EY
Mara Gordon, Co-founder & Chief Process Engineer, The Oil Plant
Thomas Marcotte, MD, Co-Director, Center for Medicinal Cannabis Research – UC San Diego
Amy Oppedisano, Co- Founder, Terra Tech Corp. (Owner of Blüm)
Robert Solomon, Co-Chair, UCI Center for the Study of Cannabis
Closing Day 1
Medical Technology Innovation Forum
October 28-29, 2019
Newport Beach Marriott Hotel & Spa
Join Our Ecosystem
We’ll keep you updated on all things OCTANe.